Abstract
The factors influencing the response of essential tremor to prolonged administration of propranolol (120 mg daily for two weeks followed by 240 mg daily for a further two weeks) were investigated in a double-blind, cross-over, placebo-controlled study in 16 patients. Hand tremor was assessed by means of accelerometers with off-line computer analysis. Propranolol was found to be superior to placebo only at the higher dosage regimen (240 mg daily). At this dosage, the median reduction in tremor amplitude (as compared to the control value) was by 45%. The response to the drug (expressed as percentage change in tremor amplitude) was correlated positively with the control amplitude (rs = 0.71, p < 0.01) and negatively (but more weakly) with the control peak frequency of tremor (rs = -0.53, p < 0.05). In the patients with hand tremor greater than 6 x 10(-3) cm hand displacement the tremor amplitude was reduced by 65%, as compared to only 17% in patients whose tremor amplitude was below this limit. No statistically significant relationship could be found between percentage change in tremor amplitude and duration of the disorder, age of the patients, degree of cardiac beta-blockade or serum propranolol levels. The results suggest that patients with small tremor amplitude should not be treated with propranolol unless their tremor becomes severely aggravated under conditions of excessive adrenergic discharge.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Calzetti S., Findley L. J., Gresty M. A., Perucca E., Richens A. Metoprolol and propranolol in essential tremor: a double-blind, controlled study. J Neurol Neurosurg Psychiatry. 1981 Sep;44(9):814–819. doi: 10.1136/jnnp.44.9.814. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dupont E., Hansen H. J., Dalby M. A. Treatment of benign essential tremor with propranolol. A controlled clinical trial. Acta Neurol Scand. 1973;49(1):75–84. doi: 10.1111/j.1600-0404.1973.tb01280.x. [DOI] [PubMed] [Google Scholar]
- Jefferson D., Jenner P., Marsden C. D. Relationship between plasma propranolol concentration and relief of essential tremor. J Neurol Neurosurg Psychiatry. 1979 Sep;42(9):831–837. doi: 10.1136/jnnp.42.9.831. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Marsden C. D., Gimlette T. M., McAllister R. G., Owen D. A., Miller T. N. Effect of beta-adrenergic blockade on finger tremor and Achilles reflex time in anxious and thyrotoxic patients. Acta Endocrinol (Copenh) 1968 Mar;57(3):353–362. doi: 10.1530/acta.0.0570353. [DOI] [PubMed] [Google Scholar]
- McAllister R. G., Jr, Markesbery W. R., Ware R. W., Howell S. M. Suppression of essential tremor by propranolol: correlation of effect with drug plasma levels and intensity of beta-adrenergic blockade. Ann Neurol. 1977 Feb;1(2):160–166. doi: 10.1002/ana.410010210. [DOI] [PubMed] [Google Scholar]
- Murray T. J. Long-term therapy of essential tremor with propranolol. Can Med Assoc J. 1976 Nov 6;115(9):892–894. [PMC free article] [PubMed] [Google Scholar]
- Nygard G., Shelver W. H., Wahba Khalil S. K. Sensitive high-pressure liquid chromatographic determination of propranolol in plasma. J Pharm Sci. 1979 Mar;68(3):379–381. doi: 10.1002/jps.2600680336. [DOI] [PubMed] [Google Scholar]
- Sørensen P. S., Paulson O. B., Steiness E., Jansen E. C. Essential tremor treated with propranolol: lack of correlation between clinical effect and plasma propranolol levels. Ann Neurol. 1981 Jan;9(1):53–57. doi: 10.1002/ana.410090110. [DOI] [PubMed] [Google Scholar]
- Teräväinen H., Fogelholm R., Larsen A. Effect of propranolol on essential tremor. Neurology. 1976 Jan;26(1):27–30. doi: 10.1212/wnl.26.1.27. [DOI] [PubMed] [Google Scholar]
- Winkler G. F., Young R. R. Efficacy of chronic propranolol therapy in action tremors of the familial, senile or essential varieties. N Engl J Med. 1974 May 2;290(18):984–988. doi: 10.1056/NEJM197405022901802. [DOI] [PubMed] [Google Scholar]